Natera Inc News - NTRA | ADVFN

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Natera Inc (NTRA)

173.39

2.66

(1.56%)

Closed February 17 4:00PM

Delayed by 15 minutes

176.00

2.61

(1.51%)

After Hours: 7:47PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer

Readout of ~1K patients at ASCO GI 2025 demonstrates that Signatera™ positive patients treated with both chemotherapy and celecoxib had a 40...

Form 4 - Statement of changes in beneficial ownership of securities

1
2
Next

PonkenPlonken

PonkenPlonken 3 months ago

now biggest pstn at Duquesne

Monksdream

Monksdream 6 months ago

NTRA new 52 week high

Monksdream

Monksdream 6 months ago

NTRA new 52=week high

Monksdream

Monksdream 6 months ago

NTRA new 52 week high

Monksdream

Monksdream 9 months ago

Pioneers in individualized genetic testing

Cell-free DNA (cfDNA) can be found in everyone. Not only do our own cells release it, so do fetal, tumor, and donor organ cells. Using a simple blood draw, our technology precisely detects each of these types of cell-free DNA, uniquely for each individual, to help proactively inform their treatment.
With more than 15 years of experience focused in this field, our technology has been used to perform more cell-free DNA tests than any other.

Monksdream

Monksdream 11 months ago

NTRA new 52 week high

Monksdream

Monksdream 12 months ago

NTRA new 52 week high

BNP Paribas Issuance

BNP Paribas Issuance

Vontobel Financial Produ...

BlackRock Enhanced Large...

Fundo Invest Financeiro ...

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock